Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Cancer Discov. 2012 Dec 10;3(2):168–181. doi: 10.1158/2159-8290.CD-12-0357

Figure 5.

Figure 5

Comparison of EGFR T790M inhibitors in human NSCLC-derived cell lines. A, NCI-H1975 (EGFR L858R/T790M), B, NCI-H820, or C, PC-9 ER (del E746_A750/T790M) cells were treated with the indicated inhibitors for 16 hr and stimulated by TGF-α for 15 min. The drug effects on EGFR phosphorylation were observed by immunoblotting and an in-cell immunodetection assay as described in Fig. 4.